GENE ONLINE|News &
Opinion
Blog

2025-11-29|

Study Analyzes Patient Experiences and Satisfaction Under India’s PM-JAY Health Insurance Scheme

by GOAI
Share To

A recent study examined patient experiences under India’s National Health Insurance Scheme, Pradhan Mantri Jan Arogya Yojana (PM-JAY). Researchers Srivastava, Parmar, Strupat, and their team conducted a mixed-methods investigation to analyze how patients interact with and perceive the healthcare services provided through this initiative. The study aimed to provide insights into the effectiveness of PM-JAY in delivering accessible and quality healthcare to its beneficiaries.

The research focused on gathering data from patients enrolled in the scheme to understand their experiences with service delivery, accessibility, and overall satisfaction. By employing both qualitative and quantitative methods, the study explored various aspects of patient care under PM-JAY. Findings from this analysis contribute valuable information for policymakers and healthcare providers seeking to improve the scheme’s implementation and ensure it meets the needs of its users effectively.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 29, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top